UK Government Invests £520m in Life Sciences Sector Growth

The UK government targets life sciences sector growth, aiming for £41bn by enhancing manufacturing and investment to improve clinical trials and innovation.

Law to Decentralize Personalized Drug Manufacturing in UK

A legislation has been passed to decentralize personalized drug manufacturing in UK thereby enabling to manufacture medicines at the point of care.

EU-US Trade Deal Taking Shape as Pharma Tariffs Materialize

As per EU-US trade deal, pharma imports along with almost all goods entering the US will be subject to 15% tariffs thereby showing clarity on further scenario.

AstraZeneca Plans $50 Billion Investment in America

AstraZeneca plans $50 billion investment in America for medicines manufacturing and R&D, aiming to create thousands of jobs and enhance production capabilities.

Magnetic Particles Steer the Vesicles for Drug Delivery

Research has demonstrated that magnetic particles steer the vesicles for targeted drug delivery which can be very effective for the treatment of cancer.

Boosting Efficiency via Smart Pure Steam Generation

Boosting Efficiency via Smart Pure Steam Generation shows how small upgrades in pharma processes can drive major energy savings and sustainability gains.

Improving Lab Efficiency Through Equipment Utilization

Elemental Machines boosts lab efficiency through equipment utilization, helping teams cut costs, reduce downtime, and optimize maintenance workflows.

Role of Technology in Enhancing Patient Engagement in Trials

Mobile apps, eCOA, ePRO, and telehealth are revolutionizing patient engagement and retention in clinical trials, making processes smoother and more inclusive.